AI Health Technology Limited

AI Health Technology Limited

HHKEX:1715
0.39
HKD
+0.00
(-1.28%)
175.09MMarket Cap
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
3.16
3.33
3.72
4.74
3.59
2.76
2.1
1.29
1.09
0.83
0.18
- -
Basic EPS, GAAP
0.26
0.35
0.3
0.38
0.27
-0.31
-0.65
-0.63
-0.64
-0.32
-0.13
- -
Free Cash Flow per Basic Share
0.14
0.01
0.2
-0.88
-0.01
-0.34
-0.19
-1.12
0.18
-0.32
-0.04
- -
Dividend per Share
0.01
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.35
0.41
0.93
2.49
2.77
2.46
1.81
1.17
0.67
0.31
0.16
0.16
Tangible Book Value per Share
0.34
0.4
0.92
2.47
2.62
2.32
1.68
1.04
0.58
0.25
0.14
0.14
Basic Weighted Avg Shares
69
69
69
59
69
69
69
69
77
110
268
251
Sales/Revenue/Turnover
217
228
255
282
246
189
144
88
84
92
47
- -
Operating Margin (%)
9.93
12.29
10.71
9.12
8.05
-15.11
-31.3
-45.45
-44.73
-32.86
-73.92
- -
Depreciation Expense
2
2
2
2
6
7
7
7
6
4
3
- -
Net Income, GAAP
18
24
20
22
19
-21
-44
-43
-49
-36
-36
- -
Effective Tax Rate (%)
14.89
13.87
21.38
16.67
10.67
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
8.08
10.48
7.99
7.95
7.62
-11.16
-30.83
-49
-58.46
-39.02
-75.02
- -
Working Capital
18
20
55
157
161
129
91
58
33
29
42
42
LT Debt
- -
- -
- -
- -
10
7
6
4
5
6
4
4
Total Equity
29
33
69
175
195
173
124
80
58
42
60
60
Return on Invested Capital (%)
- -
60.08
24.19
13.11
8.27
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
70.85
27.83
13.92
8.67
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
91.35
44.34
19.08
10.4
-11.78
-30.27
-42.24
-71.18
-71.51
-70.51
- -

Capital Structure

CNY

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
ST Debt
54
47
42
LT Borrowings
6
4
4
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
135
361
361
Market Capitalization
24
114
157

Working Capital

CNY

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
Total Current Assets
118
157
125
Cash, Cash Equivalents & STI
2
46
27
Accounts Receivable, Net
25
3
60
Inventories
31
28
17
Total Current Liabilities
88
81
82
Payables & Accruals
- -
- -
- -
ST Debt
54
47
42
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
19.92%
-15.49%
40.74%
Free Cash Flow
620.36%
-21.29%
-71.47%
Net Income, GAAP
-10.39%
18.67%
-0.81%
Sales/Revenue/Turnover
-11.47%
-21.31%
-48.41%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
84
2024
- -
- -
92
2025
- -
- -
47

Semi-annual Earnings Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
-0.64
2024
- -
- -
-0.32
2025
- -
- -
-0.13

Semi-annual Dividends Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -

Company Description

CEO
Can Yue Maeck
Full Time Employees
52
Sector
Consumer durables
Industry
Electronics/Appliances
Address
West Building No. 2 Shanghai SH China 201206
IPO Date
Jul 16, 2018
Business
AI Health Technology Limited is an investment holding company principally engaged in the research, development, manufacturing, and trading of kitchen appliances primarily in the People's Republic of China. The company offers radiant and induction hobs and stoves, pots and pans; other small kitchen appliances and cabinets including hoods, kettles, bakery ovens, and kitchen cabinets; healthcare products; and components of cooking appliances, distributed through distributors, consignment sales, television platforms, corporate clients, and online platforms. It also undertakes events planning and organizing, research and development activities, and distribution of cabinets, electrical appliances, and kitchen equipment. Incorporated in 2017 and headquartered in Shanghai, China, the company changed its name from Volcano Spring International Holdings Limited to AI Health Technology Limited in July 2025. In recent strategic developments, AI Health Technology established its wholly-owned subsidiary Shenzhen Candong Health Technology Co. Ltd. in October 2025, forming a research and development team focused on health data analysis, intelligent services, and a one-stop health management platform utilizing AGI technology for real-time monitoring, risk assessment, personalized interventions, and integration with medical institutions. The group plans to expand into digital healthcare, wellness services, and personal care products trade, reaching preliminary cooperation agreements with suppliers from mainland China, Hong Kong, Japan, Korea, the US, and the EU; it anticipates stable revenue from this segment by Q4 2025 and significant market share growth in 2026-2027 through e-commerce channels like Tmall, JD.com, Douyin, and Dewu.